Pat has a deep understanding of a broad range of state-level laws and policies that impact biopharmaceutical manufacturers, including drug coverage and reimbursement, state efforts at drug price controls and transparency, Medicaid access, value based arrangements, and associated state laws and regulations. He has extensive experience in complex legislative and regulatory drafting related to these topics, and has particular expertise in managing multi-state legislative and regulatory advocacy initiatives focused on these and other topics on behalf of biopharmaceutical manufacturing clients. His knowledge of the intricacies of state-level policymaking reflects three years of experience in the Office of the General Counsel at the Commonwealth of Massachusetts Executive Office for Administration and Finance, where he focused on a range of legislative initiatives as well as general regulatory matters overseen by that agency.
